Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) just unveiled an update.
EZZ Life Science Holdings Ltd. announced a change in the director’s interest, with Ivan Oshry increasing his direct shareholding by converting 5,000 performance rights into ordinary shares. This change reflects a strategic move in the company’s governance, potentially impacting shareholder confidence and market perception.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Ltd. operates in the life sciences industry, focusing on the development and distribution of health and wellness products. The company is known for its innovative solutions in the biotechnology sector, catering to a diverse market with a range of health-related products.
Average Trading Volume: 69,566
Technical Sentiment Signal: Sell
Current Market Cap: A$75.71M
See more insights into EZZ stock on TipRanks’ Stock Analysis page.